Lv1
22 积分 2026-08-18 加入
Nebulized liposomal co-delivery of nintedanib and tetrandrine for enhanced treatment of pulmonary fibrosis
6小时前
待确认
Engineering Aerosol-Resilient EV-Liposome Hybrid Vesicles for Inhalable Nintedanib Delivery in Pulmonary Fibrosis
17小时前
已完结
Inhaled nintedanib nanoparticles for enhanced efficacy in idiopathic pulmonary fibrosis (IPF) treatment – Evidence in disease-relevant in-vitro models
2天前
已完结
Decoupling efficacy from toxicity: Inhalable liposomal nintedanib for safe and effective treatment of pulmonary fibrosis
3天前
已完结
Construction of the pulmonary bio-adhesive delivery system of nintedanib nanocrystalline for effective treatment of pulmonary fibrosis
3天前
已完结
Dry Powder Inhalation of Nintedanib in Dibasic Calcium Phosphate for Targeting the Lungs in Pulmonary Fibrosis
4天前
已完结
Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
8天前
已完结
Delivery Characterization of SPL84 Inhaled Antisense Oligonucleotide Drug for 3849+10 kb C- > T Cystic Fibrosis Patients
18天前
已完结
A phase I study assessing the safety and tolerability of SPL84, an inhaled antisense oligonucleotide for treatment of cystic fibrosis patients with the 3849+10kb C->T
22天前
已完结
The safety and toxicity profile of SPL84, an inhaled antisense oligonucleotide for treatment of cystic fibrosis patients with the 3849+10kb C->T mutation, supports a Phase 1/2 clinical study
25天前
已完结
皖公网安备34019202002308
